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ABSTRACT 
Despite progressive research being done on drug therapy to treat breast cancer, the number of 
patients succumbing to the disease is still a major issue. Combinatorial treatment using different 
drugs and herbs to treat cancer patients is of major interest in scientists nowadays. Doxorubicin is 
one of the most used drugs to treat breast cancer patients. The combination of doxorubicin to 
other drugs such as tamoxifen has been reported. Nevertheless, the combination of doxorubicin 
with a natural product-derived agent has not been studied yet. Morinda citrifolia has always been 
sought out for its remarkable remedies. Damnacanthal, an anthraquinone that can be extracted 
from the roots ofMorinda citrifolia is a promising compound that possesses a variety of biological 
properties. This study aimed to study the therapeutic effects of damnacanthal in combination 
with doxorubicin in breast cancer cells. Collectively, the combination of both these molecules 
enhanced the efficacy of induced cell death in MCF-7 as evidenced by the MTT assay, cell cycle, 
annexin V and expression of apoptosis-related genes and proteins. The effectiveness of 
doxorubicin as an anti-cancer drug was increased upon addition of damnacanthal. These results 
could provide a promising approach to treat breast cancer patients. 
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